Professor, Department of Psychiatry and Behavioral Sciences
Johns Hopkins University School of Medicine
Maxine Stitzer, Ph.D. is a founding faculty member of the Behavioral Pharmacology Research Unit, a nationally recognized extramural substance abuse research laboratory within the Department of Psychiatry at Johns Hopkins University School of Medicine. Her research has focused on both pharmacological and behavioral approaches to the treatment of substance use disorders including opioid, stimulant and tobacco use disorders. She is perhaps best known for her pioneering and continuing work on Contingency Management in substance abuse treatment, an approach designed to enhance motivation for positive behavior change. She has continuously sustained a productive grant-supported research program, published over 280 scientific papers and co-edited books both on medication-supported treatment for opioid use disorders and on a behavioral model of reinforcement-based treatment for SUD's. She has been the recipient of several awards for outstanding contributions to research on substance use disorders including the Marion Fishman Award from CPDD. Stitzer currently heads the Mid Atlantic Node of the National Institute on Drug Abuse Clinical Trials Network (CTN), a program in which multi-site clinical trials test the effectiveness of evidence-based and novel substance abuse treatments implemented in medical and other community settings. Overall, her research has advanced the understanding of substance use disorders broadly, the development of behavioral treatments and adoption of evidence-based treatments into clinical practice.
Friday, October 12
5:00 PM – 5:30 PM